Adam K. Simpson, Chief Executive Officer at Icosavax, Inc. (ICVX), sold 214,410 shares at $15.44 ($3.3M) on 2023-12-21, disclosed to the SEC on 2023-12-22.
Scheduled sale ($3.3M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.46 | 62,205 | $962K | 29.0% |
| 2 | $15.46 | 62,205 | $962K | 29.0% |
| 3 | $15.43 | 40,000 | $617K | 18.6% |
| 4 | $15.44 | 50,000 | $772K | 23.3% |
| Total | $15.45 avg | 214,410 | $3.3M | 100% |
| Filing → |
| ICVX | SELL | 2023-08-01 | $209K | — | Filing → |
| ICVX | SELL | 2023-02-15 | $160K | — | Filing → |
| ICVX | SELL | 2022-12-23 | $1.2M | — | Filing → |